Bharat Biotech to submit Covid nasal vaccine trial data to DCGI next month
India's drug controller had in January this year given permission to Bharat Biotech to conduct standalone phase III trials on its Covid-19 nasal vaccine.
Hyderabad: Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech on Saturday (local time) said that the clinical phase III trials of the Covid-19 nasal vaccine have been completed and the company will submit its data with Drugs Controller General of India (DCGI) next month.
In an exclusive interview with ANI, Dr Ella said, "We just completed a clinical trial, a data analysis is going on. Next month, we will submit the data to the regulatory agency. If everything is okay, then we will get permission to launch and it will be the world's first clinically proven nasal Covid-19 vaccine".
Krishna was in Paris as a speaker at Viva Technology 2022 where India was declared country of the year.
India's drug controller had in January this year given permission to Bharat Biotech to conduct standalone phase III trials on its Covid-19 nasal vaccine.
On the booster dose of Covid-19, Krishna said that those who had taken the second dose must take the booster dose.
"Booster dose of vaccine gives immunity. I always say the booster dose is a miracle dose for every vaccination. Even in children first, two doses don't give much immunity, but the third dose gives an amazing response to the child. The same thing for adults also. The third dose is very important for adults. Covid-19 can't be eradicated 100 per cent. It will be there and we have to live with it and handle it and more intelligently how to control it," he said.
Talking about the Vivatech 2022, Krishna said that this is really great achievement for India, building a brand name in France.
"I am glad to say 65 startups from India, under NITI Aayog they all came, showing that technology to a lot of people, what India can do, how India can innovate for the world. They are vibrant because I was a startup in 1997."
He said that earlier United States was the centre of startups but for the first time Indians are getting exposure in France.
"I am so happy to say the French government is very practical. They are really encouraging India and with truthfully a good heart. Again, they are really pushing how more the government can work together. How about the country's startups can work together? How government policies can create an ecosystem that is scalable, even French President Macron was talking about how to scale it up between the two partnerships, how to scale up for globe and the digitalization all that is talking about infrastructure, digitalization all that they are talking and that is a good sign between the two countries and the first time French is coming closer to India," he added.
Read also: Bharat Biotech Chief says we are able to predict pandemic based on changes in virus
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.